HSPA4 and cancer: The HSPA4 frameshift mutation seems to reduce the survival activity of tumor cells, which may partially explain why patients of gastric and colorectal cancers with microsatellite instability have better prognosis than those with microsatellite stable cancer (Jo et al., 2016).